A clinical evaluation of the ProNOVA XR polymer-free sirolimus eluting coronary stent system in the treatment of patients with de novo coronary artery lesions (EURONOVA XR I study).
about
Drug-eluting stents and acute myocardial infarction: A lethal combination or friends?From drug eluting stents to bioresorbable scaffolds; to new horizons in PCI.Longitudinal Stent Deformation at Aneurysm Site: Flexibility at the Expense of Longitudinal Integrity.Non-polymer drug-eluting coronary stents.
P2860
A clinical evaluation of the ProNOVA XR polymer-free sirolimus eluting coronary stent system in the treatment of patients with de novo coronary artery lesions (EURONOVA XR I study).
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 21 July 2013
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
A clinical evaluation of the P ...... lesions (EURONOVA XR I study).
@en
A clinical evaluation of the P ...... e novo coronary artery lesions
@nl
type
label
A clinical evaluation of the P ...... lesions (EURONOVA XR I study).
@en
A clinical evaluation of the P ...... e novo coronary artery lesions
@nl
prefLabel
A clinical evaluation of the P ...... lesions (EURONOVA XR I study).
@en
A clinical evaluation of the P ...... e novo coronary artery lesions
@nl
P2093
P2860
P1476
A clinical evaluation of the P ...... lesions (EURONOVA XR I study).
@en
P2093
Artur Klecha
Dawid Giszterowicz
Grzegorz Heba
Grzegorz L Kałuża
Jacek Dragan
Jacek Jakala
Jacek Legutko
Lukasz Partyka
Lukasz Rzeszutko
Swaminathan Jayaraman
P2860
P304
P356
10.1016/J.IHJ.2013.06.026
P577
2013-07-21T00:00:00Z